CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 532 enrolled
Drug / intervention
PNMIbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02421666
NCT02421666N/ACompleted

A Comparative Trial of Improving Care for Underserved Asian Americans Infected With HBV

Temple University·interventional·Posted Apr 21, 2015·Updated Oct 8, 2020

In Brief

A clinical study evaluating PNMI for Hepatitis B. Completed, enrolled 532 participants.

Detailed Summary

Asian Americans have the highest incidence, mortality and prevalence rates of hepatocellular carcinoma (HCC) among all U.S. racial and ethnic groups. The goal of this study is to investigate the efficacy of a Patient Navigator-led mobile phone text Messaging Intervention (PNMI) in improving hepatitis B follow-up care management for Asian Americans with chronic hepatitis B infection through a randomized controlled trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHepatitis B
Countries--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedApr 21, 2015
Enrollment StartSep 1, 2014
Primary CompletionJan 31, 2018
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 11.2 years ago

Interventions

PNMIbehavioral

Eligible patients received patient navigator led plus mobile phone text messaging intervention (PNMI) or standard care. Bilingually trained patient navigators were recruited from our existing patient navigator training network, received intensive training on HBV prevention, diagnosis and treatment management, and served as a liaison with respective clinical partners. The PNMI intervention offered three education sessions on HBV management and weekly CHB patient-designed educational phone-based text messages for five weeks.